Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 22Rectal Neoplasms 11Colonic Neoplasms 11Carcinoma, Hepatocellular 10Stomach Neoplasms 7Digestive System Neoplasms 3Neurotoxicity Syndromes 2Neoplasms 2Neoplasm Metastasis 2Intestinal Neoplasms 2Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Cholangiocarcinoma 2Recurrence 1Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Neoadjuvant Therapy 1Liver Neoplasms 1Intestinal Diseases 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Advanced Colorectal Cancer 1

Interventions

Sodium Chloride 2Paclitaxel 2Oxaliplatin 2Folfox protocol 2Carboplatin 2Taxes 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Pharmacogenomic Testing 1Leucovorin 1Gene Expression Profiling 1Fluorouracil 1Brachytherapy 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neurotoxicity Syndromes × Folfox protocol × Clear all
NCT05494320 2022-08-09

the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin

Ain Shams University

Unknown
120 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neurotoxicity Syndromes

NCT00884767 2009-07-08

Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin

National Cancer Institute (NCI)

Phase 2 Unknown
206 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡